DeepMed Research

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care

Not Applicable

Completed

Conditions: Colorectal Cancer
Diabetes
Breast Cancer
Coronary Heart Disease

Interventions: Other: Intervention

First Posted Date: 2011-11-09

Last Posted Date: 2017-04-28

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 6075

Registration Number: NCT01468675

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Genetic Mechanisms in Human Hypertension

Terminated

Conditions: Hypertension

First Posted Date: 2011-10-20

Last Posted Date: 2021-05-12

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 150

Registration Number: NCT01456208

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

APOL1 Gene Variants in African American Kidney Transplant Recipients

Terminated

Conditions: Transplant;Failure,Kidney
Kidney Disease
Kidney Failure, Chronic

First Posted Date: 2011-09-28

Last Posted Date: 2021-01-27

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 39

Registration Number: NCT01442402

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

The Impact of Nebivolol Versus Metoprolol on Quality of Life

Not Applicable

Terminated

Conditions: Transplant; Failure, Kidney
Hypertension

Interventions: Drug: Metoprolol succinate
Drug: Nebivolol

First Posted Date: 2011-09-27

Last Posted Date: 2017-04-20

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 11

Registration Number: NCT01441570

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Lahey Clinic, Burlington, Massachusetts, United States

Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients

Phase 4

Terminated

Conditions: Kidney Disease
Kidney Failure, Chronic

Interventions: Drug: Placebo
Drug: Aliskiren

First Posted Date: 2011-09-21

Last Posted Date: 2017-05-01

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 10

Registration Number: NCT01437943

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial

Phase 2

Completed

Conditions: Central Neuropathic Pain
Allodynia
Spinal Cord Injury

Interventions: Drug: Dextromethorphan

First Posted Date: 2011-09-19

Last Posted Date: 2017-04-04

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 26

Registration Number: NCT01435798

Locations: 🇺🇸
Translational Pain Research, Brigham and Women's Hospital, Boston, Massachusetts, United States

Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV

Not Applicable

Completed

Conditions: Mild Cognitive Impairment

Interventions: Behavioral: Alzheimer's disease risk disclosure
Behavioral: APOE genotype and Alzheimer's disease risk disclosure

First Posted Date: 2011-09-15

Last Posted Date: 2018-10-23

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 146

Registration Number: NCT01434667

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
Howard University, Washington, District of Columbia, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Caveolin-1 and Vascular Dysfunction

Phase 1

Conditions: Insulin Resistance
Hypertension

Interventions: Drug: Para-aminohippuric Acid
Drug: Angiotensin II
Drug: Norepinephrine

First Posted Date: 2011-08-31

Last Posted Date: 2022-03-14

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 120

Registration Number: NCT01426529

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Personalized Asthma Care Team

Completed

Conditions: Obesity
Asthma
Sleep Disordered Breathing

First Posted Date: 2011-08-26

Last Posted Date: 2011-08-26

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 201

Registration Number: NCT01423461

Sorbent Therapy of the Cutaneous Porphyrias

Phase 2

Completed

Conditions: Erythropoietic Protoporphyria

Interventions: Drug: Colestipol

First Posted Date: 2011-08-25

Last Posted Date: 2017-04-25

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 4

Registration Number: NCT01422915

Locations: 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy